Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Metadata
Title
Response of the primary lesion in gastric cancer to chemotherapeutic trials
Authors
Atsushi Ohtsu
Narikazu Boku
Shigeaki Yoshida
Yoshinori Miyata
Kuniaki Shirao
Yasuhiro Shimada
Minoru Kurihara
Japan Clinical Oncology Group
Publication date
01-02-1998
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 1/1998
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/BF02490094

Other articles of this Issue 1/1998

International Journal of Clinical Oncology 1/1998 Go to the issue

Case Report

Two patients with highly drug-resistant choriocarcinoma managed by multidisciplinary therapeutic modalities

Original Article

Prognostic value of pretreatment serum carcinoembryonic antigen and squamous cell carcinoma antigen levels for patients with stage I–III non-small cell lung cancer treated with radiation therapy alone

Original Article

Patterns of recurrence after complete remission with definitive radiotherapy in the treatment of malignant glioma

Original Article

Radiation therapy for bone metastasis of hepatocellular carcinoma

Case Report

A case of ovarian endometrioid adenofibroma of borderline malignancy: Evidence for estrogen-producing tumor

Editorial

The necessity of a comprehensive system of education for clinical oncologists in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits